Tag: dmetrix

New Company Ready to Heat Up Slow Digital Pathology Market

By Robert Michel, from the Volume XXII NO. 11 - August 3, 2015 issue

CEO SUMMARY: There’s a new competitor in the digital pathology marketplace with ambitious plans to deliver a fully-integrated pathologist workflow solution. Inspirata, Inc., of Tampa, Florida, made its debut in March at an international pathology conference. In this exclusive interview, Inspirata Chairman and CEO Satish K. Sanan explains his company’s strategic vision for digital pathology, along with the details of how Inspirata intends to overcome digital pathology’s return-on-investment challenge.

View Article

DMetrix, Bio-Reference Labs, US Clinical Labs, Vidalia Laboratory Services

By Robert Michel, from the Volume XVIII No. 9 - July 05, 2011 issue

DMETRIX PREPARES TO INTRODUCE CHEAPER PATHOLOGY SCANNER
PATHOLOGISTS MAY SOON BE ABLE TO PURCHASE a smaller and less expensive digital scanning system that fits on a microscope. DMetrix, Inc., of Tucson, Arizona, is working to downsize its flagship digital pathology imaging system.

Pixuan “Joe” Zhou, Ph.D, is President of DMetrix. He recently told a reporter for the

View Article

iTunes Business Model For Digital Path Scans

By Robert Michel, from the Volume XV No. 13 - September 29, 2008 issue

CEO SUMMARY: If BioImagene’s CEO is to be believed, the company is ready to deliver a digital pathology system that is robust and affordable, even in settings with just two or three pathologists. One key to the BioImagene strategy is “per scan” pricing that avoids the need for upfront capital to acquire its system. Confident

View Article

Is Digital Path Imaging Ready for Prime Time?

By Robert Michel, from the Volume XV No. 9 - July 7, 2008 issue

CEO SUMMARY: Digital pathology imaging systems are finding uses in all phases of drug discovery (discovery, pre-clinical, clinical trials), as well as education, research, and clinical. One hurdle to widespread adoption of fully digitized, whole-slide pathology imaging systems is FDA clearance that allows the use of this technology for primary diagnosis. Executives at two of

View Article

Volume XXVI No. 8 – June 10, 2019

THE U.S. HAS LOST ALMOST 18% of its pathologists since 2007. This means the U.S. has even fewer pathologists than other countries who have already suffered adverse clinical lab quality events. TDR also digs further into what this means for the industry, finding that while salaries and benefits are increasing, higher pay will come with a heavier workload. Also, in a Clinical Lab 2.0 case study, TDR walks readers through the steps Northwell Health took to help improve patient care – and add value – by using its data to identify patients who were undiagnosed or misdiagnosed.

See the full table of contents

Tag: dmetrix

Enter Your Login Credentials